Poster Presentations
Apr 15, 2010
Poster Board Number
Category 2b. CIRRHOSIS AND ITS COMPLICATIONS: b. CLINICAL ASPECTS:
| EARLY MARKERS OF BACTERIAL INFECTION IN LIVER CIRRHOSIS J. Acevedo*, J. Fernandez, M. Castro, D. Roca, P. Gines, V. Arroyo Liver Unit, Hospital Clinic i Provincial de Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. *juanacevedoh@yahoo.com | 145 |
| PROGNOSTIC VALUE OF RELATIVE ADRENAL INSUFFICIENCY IN DECOMPENSATED CIRRHOSIS J. Acevedo*, J. Fernandez, M. Castro, D. Roca, P. Gines, V. Arroyo Liver Unit, Hospital Clinic i Provincial de Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. *juanacevedoh@yahoo.com | 146 |
| INHIBITORY CONTROL TASK: FOCUS ON THE DETECTION OF MINIMAL HEPATIC ENCEPHALOPATHY P. Amodio1*, L. Ridola2, S. Schiff1, S. Montagnese1, C. Pasquale2, S. Nardelli2, I. Pentassuglio2, M. Trezza2, C. Marzano2, C. Flaiban3, P. Angeli1, P. Bisiacchi3, A. Gatta1, O. Riggio2 1Clinical and Experimental Medicine, University of Padova, Padova, 2Gastroenterology, University ' La Sapienza', Roma, 3General Psychology, University of Padova, Padova, Italy. *piero.amodio@unipd.it | 147 |
| PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH THE DEVELOPMENT OF A BROAD RANGE OF INFECTIONS IN CIRRHOSIS J.S. Bajaj*, M. Tannous, Z. Bootwala, A.J. Sanyal, D.M. Heuman Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA. *jasmohan@hotmail.com | 148 |
| PERSISTENT DEFICIT IN LEARNING OF RESPONSE INHIBITION FOLLOWING ONSET OF OVERT HEPATIC ENCEPHALOPATHY IN CIRRHOSIS J. Bajaj1*, D.M. Heuman1, C. Schubert2, D.P. Gibson3, J.B. Wade3, A. Topaz1, D. Bell1, R.T. Stravitz1, R.K. Sterling1, A.J. Sanyal1 1Gastroenterology, Hepatology and Nutrition, 2Biostatistics, 3Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA. *jasmohan@hotmail.com | 149 |
| SEVERITY OF CHRONIC COGNITIVE IMPAIRMENT IN CIRRHOSIS INCREASES WITH NUMBER OF EPISODES OF OVERT HEPATIC ENCEPHALOPATHY J. Bajaj1*, C. Schubert2, A.J. Sanyal1, D. Bell1, L. Pisney1, D.M. Heuman1 1Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 2Biostatistics, Virginia Commonwealth University, Richmond, VA, USA. *jasmohan@hotmail.com | 150 |
| URINARY MAGNETIC RESONANCE SPECTROSCOPY IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: CITRATE CORRELATES WITH ASYMMETRIC DIMETHYLARGININE AND GUT MICROBIAL SPECIES AND CAN PREDICT RECURRENCE AFTER LACTULOSE DISCONTINUATION J. Bajaj1*, M.J. McPhail2, D.M. Heuman1, D. Bell1, P. Gillevet3, M. Sikaroodi3, A.J. Sanyal1, M.I. Sharif2, J. Ridlon1, P. Hylemon1, S. Taylor-Robinson2 1Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA, 2Hepatology, Division of Medicine, Imperial College London, London, UK, 3Microbiome Analysis Center, George Mason University, Manassas, VA, USA. *jasmohan@hotmail.com | 151 |
| TRANSDERMAL RIVASTIGMINE FOR TREATMENT OF ENCEPHALOPATHY IN LIVER CIRRHOSIS - A RANDOMIZED PLACEBO CONTROLLED TRIAL (TREC TRIAL) P. Basu1*, N.J. Shah2, N. Krishnaswamy2, H. Hampole2, T. Pacana2, K. Rayapudi3, R. Brown Jr1 1Columbia University Medical Center, Manhattan, 2North Shore University Hospital at Forest Hills, Forest Hills, 3Vassar Brothers Hospital, Poughkeepsie, NY, USA. *patbasumd@aol.com | 152 |
| PORTAL HYPERTENSIVE GASTROPATHY AFTER ERADICATION OF ESOPHAGEAL VARICES BY BAND LIGATION AND ITS RELATION TO VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN THE GASTRIC MUCOSA M. Beltagy* Hepatology, Alexandria Faculty of Medicine., Alexandria, Egypt. *mohamedmos11@yahoo.com | 153 |
| LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY S. Bruno1*, S. Saibeni1, C. Vandelli2, G. Di Costanzo3, M. Felder4, M. Tommasini5, P. Andreone6, G.B. Gaeta7, G. Niro8, C. Furlan9, M. Cazzaniga10, C. Loguercio7, M. Persico7, M. Stanzione7, T. Stroffolini9, P.L. Almasio11 1AO Fatebenefratelli e Oftalmico, Milano, 2Università di Modena e Reggio Emilia, Modena, 3AO Cardarelli, Napoli, 4AO Bolzano, Bolzano, 5IRCCS Istituto Clinico Humanitas, Rozzano, 6Università di Bologna, Bologna, 7Seconda Università di Napoli, Napoli, 8IRCCS 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, 9Università di Roma 'La Sapienza', Roma, 10Università di Milano, Milano, 11Università di Palermo, Palermo, Italy. *savino.bruno@fbf.milano.it | 154 |
| IMPACT OF THE USE OF ALBUMIN FOR COMPLICATIONS OF CIRRHOSIS ON THE GLOBAL ALBUMIN CONSUMPTION AND PHARMACEUTICAL COSTS IN AN ACADEMIC HOSPITAL F. Mirici-Cappa1, P. Caraceni1*, E. Gelonesi1, V. Bevilacqua1, B. Benazzi1, M. Domenicali1, F. Trevisani1, C. Puggioli2, M. Bernardi1 1Department of Clinical Medicine, Alma Mater Studiorum University of Bologna, 2U.O. Farmacia Azienda Ospedaliera, Policlinico S.Orsola-Malpighi, Bologna, Italy. *paolo.caraceni@unibo.it | 155 |
| ANTIBIOTIC-RESISTANT BACTERIA IN SPONTANEOUS BACTERIAL PERITONITIS. IS IT TIME TO CHANGE? J. Castellote*, X. Ariza, A. Girbau, T. Broquetas, T. Lobatón, S. Salord, R. Rota, X. Xiol Hepatology Section, IDIBELL, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain. *jcastellote@bellvitgehospital.cat | 156 |
| RISK FACTORS TO CEFOTAXIME-RESITANT SPONTANEOUS BACTERIAL PERITONITIS J. Castellote*, X. Ariza, A. Girbau, L. Rodriguez, X. Vazquez, S. Salord, C. Baliellas, X. Xiol Hepatology Section, IDIBELL, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Spain. *jcastellote@bellvitgehospital.cat | 157 |
| MORTALITY AFTER SURGERY IN PATIENTS WITH LIVER CIRRHOSIS : COMPARISON BETWEEN CTP, MELD AND MELDNA SCORE H.C. Cho1*, D.H. Sinn1, H.Y. Jung1, M.S. Choi1, K.C. Koh1, S.W. Paik1, B.C. Yoo1, S.W. Kim2, J.H. Lee1 1Division of Gastroenterology, Sungkyunkwan University School of Medicine, Samsung Medical Center, 2Biostatics Team, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea. *academic77@naver.com | 158 |
| BUDD CHIARI SYNDROME: EVALUATION WITH INTRAVENOUSLY ENHANCED 3D ANGIOGRAPHY FROM MULTIDETECTOR RAW COMPUTED TOMOGRAPHY L. Dagher1*, H. Atienza2, M. Roizental3 1Gastroenterology and Hepatology, 2Radiology, 3Interventional Radiology, Policlinica Metropolitana, Caracas, Venezuela. *lucydagher@hotmail.com | 159 |
| EFFECT OF BRANCHED-CHAIN AMINO ACIDS ON AMMONIA METABOLISM IN SKELETAL MUSCLE IN PATIENTS WITH LIVER CIRRHOSIS AND HEALTHY CONTROLS MEASURED BY 13N-AMMONIA PET G. Dam1,2*, O.L. Munk1, P. Ott2, S. Keiding1,2, M. Sørensen1,2 1PET Centre, Aarhus University Hospital, Aarhus C, 2Department of Medicine V, Aarhus University Hospital, Aarhus, Denmark. *dam@pet.auh.dk | 160 |
| THDP-17 INHIBITS THE GLUTAMINASE ACTIVITY IN CACO-2 CELL CULTURES M.M. Díaz Herrero1,2*, J.A. del Campo2, P. Carbonero1, M. Jover2, J. Vega Perez3, F. Iglesias Guerra3, I. Periñán3, J.D. Bautista1,2, M. Romero Gómez2 1Dpto Bioquímica y Biología Molecular y Ciberehd. Facultad de Farmacia, Universidad de Sevilla, 2UGC de Enfermedades Digestivas y CIBERehd. Hospital Universitario de Valme, 3Dpto Química Orgánica y Química Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. *m.mar.dh@gmail.com | 161 |
| BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES E. Dionigi*, M. Garcovich, V. Vemala, D.W. Patch, D. Thorburn, A.K. Burroughs, J.P. O'Beirne Sheila Sherlock Liver Centre, Royal Free and University College School of Medicine, London, UK. *elenadionigi@yahoo.it | 162 |
| ASSESSMENT OF ADRENOCORTICAL RESERVE IN STABLE PATIENTS WITH CIRRHOSIS G. Fede1*, L. Spadaro1, T. Tomaselli1, G. Privitera1, J. O'Beirne2, M. Garcovich2, E. Tsochatzis2, A.K. Burroughs2, F. Purrello1 1Internal Medicine, University of Catania - Garibaldi Hospital, Catania, Italy, 2Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK. *g_fede@tiscali.it | 163 |
| EARLY IDENTIFICATION OF PROGNOSTIC FACTORS OF DEATH IN ACUTE-ON-CHRONIC LIVER FAILURE A. Escorsell1,2, F. Torres3, I. Bookman1, A. Mas1,2, J. Rios3, J. Fernandez1,2*, P. Ginès1,2 1ICU Liver Unit, Hospital Clínic, 2IDIBAPS, University of Barcelona, 3Statistical Department, Hospital Clínic, Barcelona, Spain. *aescor@clinic.ub.es | 164 |
| MELD, PROTEIN MALNUTRITION AND PREVIOUS INFECTIONS ARE PREDICTORS OF BACTERIAL INFECTIONS AND SEPSIS IN CIRRHOTIC PATIENTS V. Giannelli1*, C. Lucidi1, M. Giusto1, A. Ruffa1, O. Riggio1, L. Ridola1, M. Venditti2, A.F. Attili1, M. Merli1 1Gastroenterology. Dept of Clinical Medicine, 2Infectious and Tropical Diseases, University “La Sapienza” of Rome, Rome, Italy. *mr_valegiann84@hotmail.it | 165 |
| CONTRAST-ENHANCED CARDIAC MRI REVEALS PATHOLOGICAL MYOCARDIAL ALTERATIONS - CIRRHOTIC CARDIOMYOPATHY LINKED TO PORTAL HYPERTENSION D. Gotthardt1*, K.H. Weiss1, A. Zahn1, W. Stremmel1, P. Sauer1, D. Lossnitzer2 1Innere Medizin IV, 2Innere Medizin III, Universitätsklinik Heidelberg, Heidelberg, Germany. *daniel_gotthardt@med.uni-heidelberg.de | 166 |
| CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH CHRONIC LIVER DISEASE AND LEPTOSPIRA INFECTION D.K. Chhina1, O. Goyal2*, P. Goyal2, R. Kumar1, R.S. Chhina2 1Dept of Microbiology, 2Dept of Gastroenterology, DMC and Hospital, Ludhiana, India. *goyalomesh@yahoo.co.in | 167 |
| EVALUATION OF THE FUNCTIONAL CCL2 PROMOTER POLYMORPHISM -2518A>G AS RISK FACTOR FOR SPONTANEOUS BACTERIAL PERITONITIS AND DEATH IN DECOMPENSATED LIVER CIRRHOSIS F. Grünhage1*, B. Appenrodt2, M. Gentenmann2, L. Thyssen2, S. Schwartz2, T. Sauerbruch2, F. Lammert1 1Medical Department II, Saarland University Hospital, Homburg, 2Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany. *frank.gruenhage@uks.eu | 168 |
| CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIAL L. Hobolth1*, S. Møller2, H. Grønbæk3, S. Keiding4, F. Bendtsen1, E. Feldager1 1Department of Gastroenterology, 2Department of Clinical Physiology and Nuclear Medicine, Hvidovre University Hospital, Hvidovre, 3Department of Medicine, 4PET Center, Aarhus University Hospital, Aarhus, Denmark. *lise@hobolth.dk | 169 |
| HEPATOGENOUS DIABETES MELLITUS IN LIVER CIRRHOSIS: RELATIONSHIP WITH PORTAL PRESSURE AND VARICEAL HEMORRHAGE M.Y. Kim1*, S.K. Baik1, C.S. Won1, J.W. Byun1, H.J. Park1, H.J. Choi1, Y.O. Jang1, S.Y. Park1, Y.H. Kwon1, D.J. Kim2, J.H. Kim2, G.J. Cheon3, Y.D. Kim3, S.J. Lee4, D.H. Choi4 1Department of Internal Medicine and Institute of Basic Medical Science, Yonsei University Wonju College of Medicine, Wonju, 2Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, 3Department of Internal Medicine, Kangneung Asan Hospital, Ulsan University College of Medicine, Kangneung, 4Department of Internal Medicine, Kangwon National University College of Medicine, Chuncheon, Republic of Korea. *drkimmy@yonsei.ac.kr | 170 |
| PORTAL HYPERTENSIVE GASTROPATHY CORRELATE WITH PORTAL HYPERTENSION AND PROGNOSIS IN LIVER CIRRHOSIS M.Y. Kim1*, S.K. Baik1, C.S. Won1, J.W. Byun1, H.J. Park1, J.S. Park1, S.Y. Park1, Y.H. Kwon1, Y.D. Kim2, G.J. Cheon2 1Department of Internal Medicine and Institute of Basic Medical Science, Yonsei University Wonju College of Medicine, Wonju, 2Department of Internal Medicine, Kangneung Asan Hospital, Ulsan University College of Medicine, Kangneung, Republic of Korea. *drkimmy@yonsei.ac.kr | 171 |
| BEDSIDE REAGENT STRIP ANALYSIS OF ASCITES CAN RELIABLY RULE OUT SPONTANEOUS BACTERIAL PERITONITIS AND IS A COST-EFFECTIVE STRATEGY J.J. Kuiper*, H.R. van Buuren, R.A. de Man Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands. *j.j.kuiper@erasmusmc.nl | 172 |
| RIGTH ATRIAL PRESSURE IS NOT ADEQUATE TO CALCULATE THE PORTAL PRESSURE GRADIENT IN CIRRHOSIS. A CLINICAL-HEMODYNAMIC CORRELATION STUDY V. La Mura*, J.G. Abraldes, A. Berzigotti, E. Erice, A. Flores-Arroyo, J.C. García-Pagán, J. Bosch Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-IDIBAPS, University of Barcelona and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Barcelona, Spain. *lamugiova1@virgilio.it | 173 |
| VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION V. La Mura*, J.C. Reverter, A. Flores-Arroyo, M. Hernández-Guerra, J.G. Abraldes, J.C. García-Pagán Liver Unit, Hospital Clinic-IDIBAPS and CIBERehd, Barcelona, Spain. *lamugiova1@virgilio.it | 174 |
| IMPACT OF TIGHT GLYCEMIC CONTROL IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER DISEASE ADMITTED TO INTENSIVE CARE: RESULTS OF A SINGLE-CENTRE RANDOMIZED CONTROLLED TRIAL W. Laleman1*, A. Moonen1, C. Verslype1, P. Meersseman2, F. Nevens1, G. Van den Berghe3, A. Wilmer2 1Hepatology, 2Medical Intensive Care, 3Surgical Intensive Care, University Hospital Gasthuisberg, Leuven, Belgium. *wim.laleman@uzleuven.be | 175 |
| BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY C. Lucidi1*, V. Giannelli1, M. Giusto1, A. Ruffa1, P.A. Galtieri1, M. Venditti2, A.F. Attili1, O. Riggio1, M. Merli1 1Gastroenterology. Dept of Clinical Medicine, 2Infectious and Tropical Diseases, University “La Sapienza” of Rome, Rome, Italy. *clucidi@hotmail.it | 176 |
| SPLANCHNIC DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS L. Hobolth1, E. Christensen2, C.W. Dumcke3, F. Bendtsen1, S. Moeller4* 1Medical Gastroenterology, Hvidovre Hospital, Hvidovre, 2Medical Gastroenterology I, Bispebjerg Hospital, 3Nuclear Medicine, Rigshospitalet, Copenhagen, 4Clinical Physiology and Nuclear Medicine 239, Hvidovre Hospital, Hvidovre, Denmark. *soeren.moeller@hvh.regionh.dk | 177 |
| DE NOVO EXTRAHEPATIC MALIGNANCIES IN A COHORT OF CIRRHOTIC PATIENTS M. Montealegre Barrejon*, J.M. Moreno Planas, A. Caramuto Martins, A.B. Galera Rodenas, E. Cascales Martinez, M. Vargas Travaglini, D.F. Garcia Nuñez, A.J. Velasco Valcarcel, M.D.M. Vicente Gutiérrez, R. Pérez Flores Aparato Digestivo, Complejo Hospitalario Universitario de Albacete, Albacete, Spain. *montealegre_m@hotmail.com | 178 |
| A PROSPECTIVE COHORT STUDY INVESTIGATING THE NATURAL HISTORY OF ACUTE-ON-CHRONIC LIVER FAILURE F. Nevens1*, A. Katoonizadeh1, C. Verslype1, G. Maleux2, T. Roskams3, A. Wilmer4, W. Laleman1 1Hepatology, 2Interventionale Radiology, 3Morphology and Molecular Pathology, UZ Gasthuisbrg, Leuven, 4Medical Intensive Care Unit, UZ Gasthuisbrg, Leuven, Belgium. *frederik.nevens@uzleuven.be | 179 |
| ORAL L-ORNITHINE-L-ASPARTATE (LOLA) FOR PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY TREATED WITH LACTULOSE; A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL S. Nimanong1*, C. Siwaporn1, I. Sansak1, T. Tanwandee1, P. Charatcharoenwitthaya1, W. Chotiyaputta1, K. Boonyapisit2, N. Pausawasdi1, W. Prachayakul1, S. Pongprasobchai1, S. Leelakusolvong1, S. Manatsathit1, U. Kachintorn1 1Division of Gastroenterology, Department of Medicine, Siriraj Hospital, Mahidol University, 2Division of Neurology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. *supotgi@gmail.com | 180 |
| TREATMENT BY RADIOFREQUENCY ABLATION FOLLOWED BY SALVAGE TRANSPLANTATION IN PATIENTS WITH CHILD PUGH A CIRRHOSIS AND HCC WITHIN MILAN CRITERIA G. Nkontchou1*, O. Seror1, M. Aout2, A. Laurent3, N. Ganne Carrie1, V. Grando Lemaire1, J.-C. Trinchet1, D. Cherqui4, E. Vicaut2, M. Beaugrand1 1Jean Verdier Hospital Université Paris 13, Bondy, 2Clinical Research Unit, Lariboisière Hospital, Paris, 3Surgical Unit, Henri Mondor Hospital, 4Surgery Unit, Henri Mondor Hospital, Creteil, France. *gisele.nkontchou@jvr.ap-hop-paris.fr | 181 |
| THERAPEUTIC EFFICACY OF L-ORNITHINE-L-ASPARTATE INFUSIONS IN PATIENTS WITH CIRRHOSIS AND HEPATIC ENCEPHALOPATHY N. Oruc1*, A. Ozturk1, I.K. Onal2, N.G. Unal1, M. Akdogan2, C. Yurdaydin3, Z. Karasu1, O. Ozutemiz1 1Gastroenterology, Ege University Faculty of Medicine, Izmir, 2Gastroenterology, Yuksek Ihtisas Training Hospital, 3Gastroenterology, Ankara University, Faculty of Medicine, Ankara, Turkey. *nevintr@yahoo.com | 182 |
| MANNOSE-BINDING LECTIN DEFICIENCY CONFERS RISK FOR INFECTIONS IN A LARGE HUNGARIAN COHORT OF PATIENTS WITH LIVER CIRRHOSIS M. Papp1*, Z. Vitalis1, I. Tornai1, K. Palatka1, S. Kacska1, G. Farkas1, M. Udvardy1, J. Harsfalvi2, T. Dinya3, P. Orosz4, B. Lombay5, A. Par6, G. Par6, T. Csak7, J. Osztovics7, F. Szalay7, A. Csepregi8, P.L. Lakatos7, I. Altrojay1 12nd Department of Medicine, Division of Gastroenterology, 2Clinical Research Centre, 3Institute of Surgery, University of Debrecen, 4Gatroenterology Department of Medicine, Borsod-Abauj Zemplen County Hospital, 5Department of Medicine, Szent Ferenc Hospital, Debrecen, 61st Department of Medicine, University of Pecs, Pecs, 71st Department of Medicine, Semmelweis University, Budapest, Hungary, 8Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany. *drpappm@yahoo.com | 183 |
| MONTHLY IBANDRONATE VS. WEEKLY ALENDRONATE IN THE TREATMENT OF OSTEOPOROSIS ASSOCIATED WITH PRIMARY BILIARY CIRRHOSIS: SIMILAR EFFICACY BUT DIFFERENT ADHERENCE A. Parés1*, D. Cerdá2, A. Monegal2, A. Muxi2, L. Caballeria1, P. Peris2, F. Pons2, N. Guañabens2 1Liver Unit, 2Metabolic Bone Diseases Unit, Hospital Clínic, CIBERhed, IDIBAPS, University of Barcelona, Barcelona, Spain. *apares@clinic.ub.es | 184 |
| MINIMAL HEPATIC ENCEPHALOPATHY (MHE): SIMPLIFIED DIAGNOSIS AND RELATIONSHIP WITH THE DEVELOPMENT OF OVERT HEPATIC ENCEPHALOPATHY (OHE) C. Pasquale1*, L. Ridola1, I. Pentassuglio1, S. Nardelli1, M. Trezza1, C. Marzano1, C. Merkel2, O. Riggio1 1Clinical Medicine, Sapienza University of Rome, Rome, 2Clinical and Experimental Medicine, University of Padua, Padua, Italy. *chiara_1985@hotmail.com | 185 |
| PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: SAFETY AND EFFICACY OF LOW DOSAGE OF ENOXAPARIN A.M. Pellicelli1*, P. Guarascio1, C. D'Ambrosio1, A.E. Lusi1, R. Villani1, L. Fondacaro1, G. Cerasari1, G. Liotta2, G. Vennarecci2, R. Santoro2, G.M. Ettorre2, A. Andreoli1 1Liver Unit, Azienda Ospedaliera San Camillo Forlanini, 2Surgical Oncology and Liver Transplantation Unit, POIT San Camillo Forlanini-Spallanzani, Rome, Italy. *adriano.pellicelli@tiscali.it | 186 |
| A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION TRIAL USING THE ONCE-DAILY ORAL CHELATOR DEFERASIROX TO TREAT IRON OVERLOAD IN HFE-RELATED HEREDITARY HEMOCHROMATOSIS: FINAL RESULTS P. Phatak1*, P. Brissot2, M. Wurster3, P.C. Adams4, H.L. Bonkovsky5, J. Gross6, P. Malfertheiner7, G.D. McLaren8,9, C. Niederau10, A. Piperno11, L.W. Powell12, M. Russo13, U. Stoelzel14, W. Stremmel15, L. Griffel16, N. Lynch16, Y. Zhang16, A. Pietrangelo17 1Rochester General Hospital, Rochester, NY, USA, 2Rennes University Hospital, Rennes, France, 3Ohio State University Medical Center, Columbus, OH, USA, 4University Hospital, London, ON, Canada, 5Cannon Research Center at Carolinas Health Care System, Charlotte, NC, 6Mayo Clinic, Rochester, MN, USA, 7Medizinische Fakultat der Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany, 8University of California, Irvine, 9VA Medical Center, Long Beach, CA, USA, 10St Josef Hospital, University of Essen, Oberhausen, Germany, 11Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy, 12Royal Brisbane and Women's Hospital and the University of Queensland, Brisbane, QLD, Australia, 13Carolinas Medical Center, Charlotte, NC, USA, 14Klinikum Chemnitz, Chemnitz, 15University Hospital, Heidelberg, Germany, 16Novartis Pharmaceuticals Corp., East Hanover, NJ, USA, 17University of Modena and Reggio Emilia, Modena, Italy. *prad.phatak@rochestergeneral.org | 187 |
| FACTORS PREDICTING IN-HOSPITAL MORTALITY IN CIRRHOTIC PATIENTS PRESENTING WITH SEPSIS A. Rajnakova1*, L.G. Lim1, E. Tan2, Y.Y. Dan1,3, Y.M. Lee1, V. Lai1, S.G. Lim1,3 1National University Health System, 2National University High School, 3Yong Yoo Lin School of Medicine, Singapore, Singapore. *andrea_rajnakova@yahoo.com | 188 |
| MILD HEPATIC ENCEPHALOPATHY (HE) ASSESSED BY THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS (RBANS) IS HIGHLY PREVALENT IN AMBULATORY PATIENTS WITH CIRRHOSIS C. Randolph1*, J. Bajaj2, M.Y. Sheikh3, R. Vemuru4, G. Morelli5, L.A. Balart6, M. Chojkier7, M.S. Harris8, J.D. Bornstein8, K. Mullen9 1Loyola University Med. Center, Chicago, IL, 2McGuire DVAMC, Richmond, VA, 3University of California at San Francisco (UCSF), Fresno Medical Educational Program, Fresno, CA, 4Permian Research Foundation, Odessa, TX, 5University of Florida, Gainesville, FL, 6Tulane University, New Orleans, LA, 7Veterans Medical Center San Diego, 8Ocera Therapeutics, San Diego, CA, 9Case Western Reserve University, Cleveland, OH, USA. *crandol@lumc.edu | 189 |
| PREVALENCE OF DIASTOLIC DYSFUNCTION AND OTHER SUPPORTIVE CRITERIA OF CIRRHOTIC CARDIOMYOPATHY H. Ribeiro1*, J. Presa2, R. Margato1, S. Carvalho1, C. Ferreira1, P. Mateus1, A. Ferreira1, J.I. Moreira1 1Cardiology, 2Internal Medicine, CHTMAD, Vila Real, Portugal. *hjmribeiro@gmail.com | 190 |
| CLINICAL EFFICACY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATED WITH COVERED STENTS WITH DIFFERENT DIAMETERS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL O. Riggio1, L. Ridola1*, S. Angeloni1, F. Cerini1, F. Fanelli2, F.M. Salvatori2, M. Merli1 1Clinical Medicine, 2Radiology, Sapienza University of Rome, Rome, Italy. *lorenzoridola@tiscali.it | 191 |
| INHIBITORY CONTROL TEST DOES NOT IDENTIFY THE PATIENTS AT RISK OF DEVELOPING OVERT HE IN AN ITALIAN POPULATION OF CIRRHOTIC PATIENTS L. Ridola*, C. Pasquale, I. Pentassuglio, S. Nardelli, M. Trezza, C. Marzano, M. Merli, O. Riggio Clinical Medicine, Sapienza University of Rome, Rome, Italy. *lorenzoridola@tiscali.it | 192 |
| REPEAT MEASUREMENTS DO NOT ADD FURTHER INFORMATION TO SINGLE MEASUREMENTS IN THE PREDICTION OF OUTCOMES IN CIRRHOSIS P. Lastra, C. Ripoll*, D. Rincón, V. Catalina, R. Bañares Liver Unit. Digestive Disease Department, Hospital General Universitario Gregorio Marañon, CiberEHD, Madrid, Spain. *cristina_ripoll@yahoo.es | 193 |
| THE NATURAL HISTORY OF HEPATIC MACROREGENERATIVE NODULES DEVELOPING IN CIRRHOTIC PATIENTS DURING SURVEILLANCE WITH ULTRASOUND A. Sangiovanni1*, C. Della Corte1, M.A. Manini1, M. Iavarone1, S. Vavassori1, R. Romeo1, M. Fraquelli2, A. Aghemo1, M. Colombo1 1A.M. & A. Migliavacca, Division of Gastroenterology 1, 2Division of Gastroenterology 2, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli & Regina Elena, Università degli Studi di Milano, Milan, Italy. *angelo.sangiovanni@policlinico.mi.it | 194 |
| RIFAXIMIN DECREASES VENOUS AMMONIA CONCENTRATIONS AND TIME-WEIGHTED AVERAGE AMMONIA CONCENTRATIONS CORRELATE WITH OVERT HEPATIC ENCEPHALOPATHY (HE) AS ASSESSED BY CONN SCORE IN A 6‑MONTH STUDY A. Sanyal1*, N. Bass2, F. Poordad3, M.Y. Sheikh4, K. Mullen5, S. Sigal6, T. Frederick7, R. Brown Jr.8, B. Bhandari9, S. Sedghi10, K. Merchant11, S. Huang11, A. Shaw11, E. Bortey11, W.P. Forbes11 1Virginia Commonwealth University, Richmond, VA, 2University of California, San Francisco, 3Cedars-Sinai Medical Center, Los Angeles, 4University of California at San Francisco, Fresno MEP, CA, 5Case Western Reserve, Cleveland Clinic, Cleveland, OH, 6Weill Medical College of Cornell University, New York, NY, 7California Pacific Medical Center, San Francisco, CA, 8Columbia University Medical Center, New York, NY, 9Delta Research Partners, LLC, Monroe, LA, 10Gastroenterology Associates of Central Georgia, LLC, Macon, GA, 11Salix Pharmaceuticals, Inc., Morrisville, NC, USA. *asanyal@mcvh-vcu.edu | 195 |
| PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS F. Schepis1*, M. Bianchini1, I. Ferretti1, M. Marino1, S. Bonfreschi1, G. Dattomo1, F. Agnello1, M.L. Wratten2, N. De Maria1, E. Villa1 1Azienda Ospedaliero - Universitaria di Modena, Modena, 2BRAHMS Italia, Milan, Italy. *filippo.schepis@unimore.it | 196 |
| BACTERIAL DNA DETECTION BY REAL-TIME PCR AND 16S RDNA GENE SEQUENCING IN SPONTANEOUS BACTERIAL PERITONITIS G. Soriano1*, O. Esparcia2, M. Montemayor2, C. Guarner-Argente1, R. Pericas2, X. Torras1, N. Calvo3, E. Román1, F. Navarro2, C. Guarner1, P. Coll2 1Department of Gastroenterology, CIBERehd, 2Department of Microbiology, 3Department of Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. *gsoriano@santpau.cat | 197 |
| RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS FOR THE REDUCTION OF PORTAL PRESSURE: A META-ANALYSIS AND SYSTEMATIC REVIEW P. Tandon*, J.G. Abraldes, A. Berzigotti, J.C. Garcia-Pagán, J. Bosch Hospital Clinic de Barcelona, Barcelona, Spain. *ptandon@ualberta.ca | 198 |
| THE EFFECTS OF DISEASE STAGE AND ACUTE-ON-CHRONIC LIVER FAILURE ON THE PROFILE OF PLASMA DIMETHYLARGININES IN CIRRHOSIS S.J. Thomson1*, M.L. Cowan1, S. Musa1, R.N. Dalton2, C. Turner2, D.M. Forton1, S.J. Clark1, T.M. Rahman1 1Hepatology, St George's Hospital, 2Paediatric Biochemistry, King's College, Evelina Children's Hospital, London, UK. *sthomson@sgul.ac.uk | 199 |
| INFECTION AND HISTORY OF INFECTION ARE INDEPENDENT OF MELD FOR PROGNOSIS IN CIRRHOSIS A. Tsami*, E. Tsochatzis, V. Arvaniti, M. Garcovich, J. O'Beirne, A.K. Burroughs The Royal Free Sheila Sherlock Liver Centre and Division of Surgery, Royal Free Hospital NHS Trust, London, UK. *tsamicat@yahoo.it | 200 |
| PORTOPULMONARY HYPERTENSION AND SERUM ENDOTHELIN LEVELS IN PATIENTS WITH CIRRHOSIS A.P. Tsiakalos1*, G. Hatzis1, I. Moyssakis2, A. Karatzaferis1, P.D. Ziakas1, G.E. Tzelepis1 1Department of Pathophysiology, National University of Athens, School of Medicine, 2Department of Cardiology, Laikon General Hospital, Athínai, Greece. *atsiakalos@gmail.com | 201 |
| A CASE CONTROL STUDY OF IMPACT: A BRIEF AND EFFECTIVE WEB-BASED NEUROPSYCHOLOGICAL ASSESSMENT BATTERY TO DIAGNOSE MINIMAL HEPATIC ENCEPHALOPATHY (MHE) M. Tsushima1*, W. Tsushima,2, V. Tsushima3, N. Lim1, E. Madrigal1, C. Jackson4, M. Mendler1,5 1Division of GI and Liver Diseases, Loma Linda University Medical Center, Loma Linda, CA, 2Department of Psychiatry and Psychology, Straub Clinic and Hospital, 3Department of Psychology, Hawaii Pacific University, Honolulu, HI, 4Division of GI and Liver Diseases, Loma Linda VA Medical Center, 5Transplantation Insitute, LLUMC, Loma Linda, CA, USA. *mmendler@llu.edu | 202 |
| ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? P. Ventura1*, M. Ferrari1, A.C. Nuzzo2, F. Nascimbeni1, E. Romagnoli1, R. Rossi2, V. Moriondo1, A. Vegetti1, M.G. Modena2, A. Pietrangelo1 1Dept. of Medicines and Medical Specialities, 2Dept. of Urgency and Emergency, University of Modena and Reggio Emilia, Modena, Italy. *paoloven@unimore.it | 203 |
| SAFETY, EFFICACY AND PREDICTORS OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN REFRACTORY HEPATIC HYDROTHORAX R. Yellapu1*, A. Goldstein2, S. Anondo3, T. Schiano1 1Liver Diseases, 2Internal Medicine, 3Radiology, Mount Sinai Medical Center, New York, NY, USA. *radhayellapu@yahoo.co.in | 204 |
| HCV INFECTION AND ADVANCED LIVER CIRRHOSIS WERE ASSOCIATED INSULIN RESISTANCE Y.L. He1, Z. Yan1, K. Wang1, T.Y. Chen2, M. Liu2, F. Ye2, S.L. Zhang2, S.M. Lin2, Y.R. Zhao1* 1Hepatology Institution, Xian, 2Infectious Diseases Department, XiAn JiaoTong University, Xian City, China. *zhaoyingren@sohu.com | 205 |
| REPRODUCIBILITY AND RELIABILITY OF THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) MEASUREMENT IN PATIENTS WITH CIRRHOSIS IS HIGHER USING THE BALLOON COMPARED TO THE STRAIGHT CATHETER A. Zipprich*, M. Winkler, T. Seufferlein, M.M. Dollinger First Department of Internal Medicine, Martin-Luther-University Halle, Halle, Germany. *alexander.zipprich@medizin.uni-halle.de | 206 |
| MELD VS CPS FOR PROGNOSIS IN CIRRHOSIS. RESULTS FROM A MULTICENTRE STUDY C. Triantos1, K. Zisimopoulos1*, E. Tsochatzis2, J. Vlachogiannakos3, S. Manolakopoulos4, C. Rigamonti2, J. Goulis5, E. Manesis4, J. Anastasiou3, F. Papalexi5, K. Georgiou6, A. Saveriadis3, K. Thomopoulos1, V. Margaritis1, D. Tzourmakliotis6, E. Akriviadis5, A. Archimandritis4, D. Karamanolis3, V. Nikolopoulou1, A.K. Buroughs2 1University Hospital of Patras, Patras, Greece, 2Royal Free Hospital, London, UK, 3Evangelismos General Hospital, 4Hippokration General Hospital of Athens, Athens, 5Hippocration General Hospital of Thessaloniki, Thessaloniki, 6Polyclinic General Hospital, Athens, Greece. *costaszisimo@hotmail.com | 207 |